Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Turn Biotechnologies acquires drug delivery tech from Harvard & Vesigen Therapeutics to expand mRNA aging therapies; CEO Anja Krammer aims for 2026 clinical trialsRead More

What's Trending

Q&A: Western prof discovers dinosaur footprints in South Africa

AI plans emerge as central theme in South Korean politics

The price of perfection: South Korea’s early education crisis

Trump administration invokes state secrets act on high-profile deportation case

Assisted dying could face four-year delay

Florida lawmakers may loosen child labor laws to fill jobs left by undocumented immigrants

Trump administration claims details of mass deportations are state secrets

Venezuelan migrants deported by the US ended up in a Salvadoran prison. This is their legal status

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Amazon Big Spring Sale tech deals: Huge savings on Apple, PlayStation, Samsung and more

UNLV to hire ESPN analyst, former Georgia Tech coach Josh Pastner as next basketball coach: Source

AI Talent: It’s Not Just for High Tech Anymore

Texas Tech baseball’s Brady Trombello set for return 13 months after head injury

Leave A Reply Cancel Reply

What's Trending

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN